Cipla's inhalable insulin fails to get approval for trials o
Drug maker Cipla’s plan of developing a pump-delivered inhalable form of insulin has suffered a setback with an expert committee denying it permission to conduct trials on Indian patients. The panel has said the company’s preliminary data on safety and efficacy of the trial drug is insufficient....
A●●●●a P●●●●d and 3 others like this